Hostname: page-component-745bb68f8f-mzp66 Total loading time: 0 Render date: 2025-01-08T11:19:31.675Z Has data issue: false hasContentIssue false
  • English
  • Français

Benefit and cost of repeating a severe acute respiratory coronavirus virus 2 (SARS-CoV-2) polymerase chain reaction (PCR) test after the second day of hospitalization in five hospitals during various community prevalences and vaccination rates

Part of: SARS-CoV-2/COVID-19

Published online by Cambridge University Press:  16 June 2022

Rene Bulnes ,
Mina Said ,
Melissa Bronstein ,
Jennifer Gutowski ,
Karan Alag ,
Jonathan Bress ,
Amber Dellefave ,
Dawn Riedy ,
Jose Alcantara  and
Hiloni Bhavsar
...Show all authors
Rene Bulnes
Affiliation:
Medicine Department, Rochester Regional Health, Rochester, New York
Mina Said
Affiliation:
Medicine Department, Rochester Regional Health, Rochester, New York
Melissa Bronstein
Affiliation:
Quality and Safety Department, Rochester Regional Health, Rochester, New York
Jennifer Gutowski
Affiliation:
Quality and Safety Department, Rochester Regional Health, Rochester, New York
Karan Alag
Affiliation:
Health Informatics, Rochester Regional Health, Rochester, New York
Jonathan Bress
Affiliation:
Medicine Department, Rochester Regional Health, Rochester, New York
Amber Dellefave
Affiliation:
Quality and Safety Department, Rochester Regional Health, Rochester, New York
Dawn Riedy
Affiliation:
Pathology Department, Rochester Regional Health, Rochester, New York
Jose Alcantara
Affiliation:
Health Informatics, Rochester Regional Health, Rochester, New York
Hiloni Bhavsar
Affiliation:
Quality and Safety Department, Rochester Regional Health, Rochester, New York
Bryan Gargano
Affiliation:
Executive Leadership, Rochester Regional Health, Rochester, New York
Emil Lesho*
Affiliation:
Infectious Diseases Department, Rochester Regional Health, Rochester, New York
*
Author for correspondence: Emil Lesho, E-mail: carolinelesho@yahoo.com
Get access Rights & Permissions [Opens in a new window]

Abstract

At our hospital, universal severe acute respiratory coronavirus virus 2 (SARS-CoV-2) polymerase chain reaction (PCR) testing was performed upon admission and again after 2 inpatient days. As community-wide prevalence, admission, and vaccination rates varied, the number needed to benefit fluctuated between 16 and 769 and the cost per additional detection fluctuated between $800 and $29,400. These 2 metrics were negatively associated with new hospital admissions. No other community indicator was associated with the number needed to benefit and cost per additional detection.

Type
Concise Communication
Information
Infection Control & Hospital Epidemiology , Volume 44 , Issue 1 , January 2023 , pp. 106 - 109
Check for updates
Copyright
© The Author(s), 2022. Published by Cambridge University Press on behalf of The Society for Healthcare Epidemiology of America

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

Elkrief, A, Desilets, A, Papneja, N, et al. High mortality among hospital-acquired COVID-19 infection in patients with cancer: a multicentre observational cohort study. Eur J Cancer 2020;139:181–187.CrossRefGoogle Scholar
Khonyongwa, K, Taori, SK, Soares, A, et al. Incidence and outcomes of healthcare-associated COVID-19 infections: significance of delayed diagnosis and correlation with staff absence. J Hosp Infect 2020;106:663–672.CrossRefGoogle ScholarPubMed
Lessells, R, Moosa, Y, de Oliveira, T. Report into a nosocomial outbreak of coronavirus disease 2019 (COVID-19) at Netcare St. Augustine’s Hospital. University of Kwazulu-Natal website. https://www.groundup.org.za/media/uploads/documents/staugustineshospitaloutbreakinvestigation_finalreport_15may2020.pdf. Published May 2020. Accessed January 26, 2021.Google Scholar
Pfoh, ER, Hariri, EH, Misra-Hebert, AD, Deshpande, A, Jehi, L, Rothberg, MB. Late diagnosis of COVID-19 in patients admitted to the hospital. J Gen Intern Med 2020;35:2829–2831.CrossRefGoogle ScholarPubMed
Kucirka, LM, Lauer, SA, Laeyendecker, O, Boon, D, Lessler, J. Variation in false-negative rate of reverse transcriptase polymerase chain reaction-based SARS-CoV-2 tests by time since exposure. Ann Intern Med 2020;173:262–267.CrossRefGoogle ScholarPubMed
Lesho, E, Walsh, E, Gutowski, J, et al. A cluster-control approach to a SARS-CoV-2 outbreak on a stroke ward with infection control considerations for dementia and vascular units. Infect Control Hosp Epidemiol 2021;42:1333–1339.CrossRefGoogle ScholarPubMed
Rhee, C, Baker, M, Vaidya, V, et al. Incidence of nosocomial COVID-19 in patients hospitalized at a large US academic medical center. JAMA Netw Open 2020;3:e2020498.CrossRefGoogle Scholar
Lesho, E, Reno, L, Newhart, D, et al. Temporal, spatial, and epidemiologic relationships of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) gene cycle thresholds: a pragmatic ambidirectional observation. Clin Infect Dis 2020;ciaa1248.CrossRefGoogle Scholar
In COVID-19 testing, what does yield mean? University of North Carolina website. https://gillingscovid19.unc.edu/coronavirus-questions/covid-19-testing-yield. Accessed December 8, 2021.Google Scholar
Honorio, MR, Benzon, HT, Molloy, RE. Membrane stablizers, in essentials of pain medicine and regional anesthesia, second edition. Science Direct website. https://www.sciencedirect.com/topics/medicine-and-dentistry/numbers-needed-to-treat. Published 2005. Accessed December 8, 2021.Google Scholar
Supplementary material: Image

Bulnes et al. supplementary material

Bulnes et al. supplementary material

Download Bulnes et al. supplementary material(Image)
Image 300.5 KB